Background When severe, COVID-19 shares many clinical features with bacterial sepsis. Yet,
secondary bacterial infection is uncommon. However, as epithelium is injured and barrier …

Rationale & Objective Established therapeutic interventions effectively mitigate the risk and
progression of chronic kidney disease (CKD). Countries and regions have a compelling …

Globally, there remain significant disparities in the capacity and quality of kidney care, as
evidenced by the third edition of the International Society of Nephrology Global Kidney Health …

Background Recent randomized trials have not found that polymyxin B hemoperfusion (PMX-HP)
improves outcomes for patients with sepsis. However, it remains unclear whether the …

A chronic kidney disease (CKD) causes uremic toxin accumulation and gut dysbiosis, which
further induces gut leakage and worsening CKD. Lipopolysaccharide (LPS) of Gram-…

Background Although pathogenic gut microbiota causes gut leakage, increases translocation
of uremic toxins into circulation and accelerates CKD progression, the local strain of …

Introduction Metformin is a first-line antihyperglycaemic agent for type 2 diabetes (T2DM). In
addition to glycaemic control, it offers benefits related to cardiovascular health, weight …

Uremic toxins and gut dysbiosis in advanced chronic kidney disease (CKD) can induce gut
leakage, causing the translocation of gut microbial molecules into the systemic circulation. …

We report a case of COVID‐19 in kidney transplant patient in Thailand. A 58‐year‐old 2
years post–kidney transplant recipient, with maintenance immunosuppression of tacrolimus, …

The prevalence of obesity is increasing, and the coexistence of obesity and systemic lupus
erythematosus (lupus) is possible. A high-fat diet (HFD) was orally administered for 6 months …